Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6 Gynecologic 3 Tumor-Agnostic 1 Head & Neck 1 Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 136 Cetuximab 101 pembrolizumab 83 Radiotherapy 62 Carboplatin 57 Radiotherapy, Intensity-Modulated 54 Fluorouracil 47 Docetaxel 47 Nivolumab 44 Paclitaxel 37 Radiation 21 Erlotinib Hydrochloride 19 durvalumab 18 Platinum 15 Ipilimumab 14 Gemcitabine 13 lenvatinib 12 Drug Therapy 12 Bevacizumab 12 Albumin-Bound Paclitaxel 12 vandetanib 11 Pemetrexed 11 Magnetic Resonance Spectroscopy 11 1,2-diaminocyclohexaneplatinum II citrate 11 Radiosurgery 10 Everolimus 10 tremelimumab 9 epacadostat 9 Surgical Procedures, Operative 9 Sorafenib 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × CP protocol × Head & Neck × Clear all

NCT05294900 2026-05-26

NEOS

Yonsei University

Phase 2 Completed

79 enrolled 6 charts

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡